| Literature DB >> 32059783 |
Mandeep Singh1, Katherine J L Jackson1, Jing J Wang2, Peter Schofield3, Matt A Field4, David Koppstein5, Timothy J Peters1, Deborah L Burnett3, Simone Rizzetto5, Damien Nevoltris3, Etienne Masle-Farquhar3, Megan L Faulks1, Amanda Russell1, Divya Gokal1, Asami Hanioka6, Keisuke Horikawa7, Alexander D Colella8, Timothy K Chataway9, James Blackburn3, Tim R Mercer10, David B Langley1, D Margaret Goodall11, Roy Jefferis11, Muralikrishna Gangadharan Komala12, Anthony D Kelleher5, Dan Suan13, Maureen Rischmueller14, Daniel Christ3, Robert Brink3, Fabio Luciani15, Tom P Gordon2, Christopher C Goodnow16, Joanne H Reed17.
Abstract
Pathogenic autoantibodies arise in many autoimmune diseases, but it is not understood how the cells making them evade immune checkpoints. Here, single-cell multi-omics analysis demonstrates a shared mechanism with lymphoid malignancy in the formation of public rheumatoid factor autoantibodies responsible for mixed cryoglobulinemic vasculitis. By combining single-cell DNA and RNA sequencing with serum antibody peptide sequencing and antibody synthesis, rare circulating B lymphocytes making pathogenic autoantibodies were found to comprise clonal trees accumulating mutations. Lymphoma driver mutations in genes regulating B cell proliferation and V(D)J mutation (CARD11, TNFAIP3, CCND3, ID3, BTG2, and KLHL6) were present in rogue B cells producing the pathogenic autoantibody. Antibody V(D)J mutations conferred pathogenicity by causing the antigen-bound autoantibodies to undergo phase transition to insoluble aggregates at lower temperatures. These results reveal a pre-neoplastic stage in human lymphomagenesis and a cascade of somatic mutations leading to an iconic pathogenic autoantibody.Entities:
Keywords: autoantibody; cryoglobulinemia; lymphoma; rheumatoid factor; single cell omics; somatic mutation; vasculitis
Year: 2020 PMID: 32059783 DOI: 10.1016/j.cell.2020.01.029
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582